CA125 II Assay

Known as: CA125 II, CA125-II, CA125-II Assay 
A second generation radioimmunoassay to measure serum levels of CA-125.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
01219932017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
OBJECTIVE To validate the effectiveness of a multivariate index assay in identifying ovarian malignancy compared to clinical… (More)
Is this relevant?
2003
2003
BACKGROUND In this study the clinical and technical performance of the CA125- detecting Bayer ACS:OV immunoluminometric serum… (More)
Is this relevant?
2001
2001
Our objective was to identify factors that correlate with CA125 concentrations in healthy postmenopausal women and to introduce… (More)
  • table 2
  • table 1
  • table 3
  • figure 1
Is this relevant?
1998
1998
OBJECTIVE To study the dose-response of the proliferation and secretion of CA125 II antigen with follicle stimulating hormone… (More)
Is this relevant?
1997
1997
The Byk LIA-mat CA125 II assay was compared with the Centocor IRMA CA125 II. Serum samples studied (n = 1012) were obtained from… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
1997
1997
An immunoradiometric method of the second generation (IR-MA II) is widely used to determine CA125 serum levels. In this study we… (More)
Is this relevant?
Review
1996
Review
1996
OBJECTIVE To determine the correlation between the widely used CA125 assay and a second-generation assay, CA125 II, in a large… (More)
Is this relevant?
1995
1995
CA125 II, an improved version of the conventional CA125 was compared with CA125 as to which was more useful in gynecologic… (More)
Is this relevant?
1993
1993
With use of monoclonal antibodies (moABs) M 11 and OC125, a sensitive sandwich immunoradiometric assay (IRMA) for CA125 II was… (More)
Is this relevant?
1993
1993
We made basic studies of BALL ELSA CA125-II KIT which is a solid phase two site immunoradiometric assay. The first monoclonal… (More)
Is this relevant?